Navigating the Patchwork: Corporate Practice of Medicine Compliance in a Multi-State Healthcare Landscape (2025-2026)
2026-06-07
The Corporate Practice of Medicine (CPOM) doctrine remains a critical, yet often misunderstood, compliance challenge for healthcare businesses operating across state lines. With telehealth expanding and private equity investment reshaping the industry, understanding this complex, state-specific regulatory landscape is more vital than ever. This deep dive unpacks the nuances of CPOM, offering actionable guidance for ensuring compliant operations in 2025 and beyond.
The healthcare industry's rapid evolution, fueled by technological advancements, burgeoning telehealth platforms, and aggressive private equity investment, has created unprecedented opportunities for growth. Yet, this expansion often collides with a foundational, decades-old regulatory framework: the Corporate Practice of Medicine (CPOM) doctrine. For any healthcare entity seeking to operate in multiple states, or even just expand within one, CPOM is not merely a legal detail; it is a fundamental architectural constraint that dictates business structure, operational control, and ultimately, viability. As we look to 2025 and 2026, the scrutiny on CPOM compliance is intensifying, making a deep understanding essential for mitigating risk and fostering sustainable growth.
> For more on this topic, see our analysis: [The GLP-1 Compounding Quake: FDA's Proposed Ban on 503B Bulks Reshapes Healthcare Business Models](/blog/glp1-compounding-quake-fda-503b-bulks-ban).
What is the Corporate Practice of Medicine (CPOM)? The Core Principle
At its heart, the CPOM doctrine generally prohibits corporations, or any non-licensed entity, from practicing medicine or employing physicians to provide medical services. The underlying rationale is to safeguard the independent professional judgment of licensed medical professionals, preventing lay interference in clinical decision-making and protecting patients from potential conflicts of interest driven by corporate profit motives. It ensures that medical services are rendered by individuals accountable to a state licensing board, not primarily to corporate shareholders.
> For more on this topic, see our analysis: [The Unseen Hand: Navigating Corporate Practice of Medicine (CPOM) Across State Lines in 2025-2026](/blog/cpom-compliance-multi-state-telehealth-2025).
While the principle sounds straightforward, its application is anything but. CPOM laws vary significantly by state, creating a complex, often contradictory, regulatory patchwork. Some states vigorously enforce broad prohibitions, while others have numerous exceptions or no explicit CPOM doctrine at all. This divergence is the primary source of complexity for multi-state operators.
The State-by-State Labyrinth: A Spectrum of Enforcement
Understanding where a state falls on the CPOM enforcement spectrum is the first critical step for any healthcare business. Broadly, states can be categorized into three groups:
1. Strict Enforcement States (High Risk)
These states have strong CPOM prohibitions, actively enforced through statutes, regulations, or case law. They typically restrict corporations from employing physicians, dictating medical fees, or controlling clinical decisions. Operations in these states almost invariably require a Professional Corporation (PC) or Professional Limited Liability Company (PLLC) model where licensed physicians maintain ownership and control of the medical entity.
Examples: * California: One of the most stringent CPOM states. Explicitly prohibits lay corporations from practicing medicine. The Medical Board of California actively investigates and prosecutes violations. Any MSO arrangement must ensure strict separation of clinical and administrative functions. The corporate entity cannot employ physicians or other licensed professionals (e.g., PAs, NPs) for the provision of medical services. *See California Business and Professions Code §§ 2052, 2400.* * Texas: Another state with robust CPOM enforcement. The Texas Medical Board maintains a firm stance against non-physician control over medical practices. The MSO model is common but requires careful structuring to avoid perceived control over medical services. *See Texas Occupations Code § 151.056.* Texas also has strong anti-fee-splitting provisions. * New York: Generally prohibits the corporate practice of medicine, with specific exceptions for certain entities like hospitals or non-profits. For-profit medical practices typically must be structured as Professional Service Corporations (PC) or PLLCs owned by licensed professionals. *See New York Education Law § 6512, NY Business Corporation Law § 1503.* * Colorado: Has a long-standing CPOM doctrine, often enforced through interpretations by the Colorado Medical Board. Employment of physicians by lay corporations is generally prohibited, necessitating physician-owned professional entities. * New Jersey: Strong CPOM restrictions. Corporations cannot practice medicine or employ physicians, necessitating physician ownership of the practice entity.
Common Pitfalls in Strict States: * Lay Ownership of Clinical Entity: Non-physician owners or shareholders in the entity providing medical services. * Corporate Control of Clinical Decisions: Clauses in management agreements that give a non-physician entity power over hiring/firing of clinical staff, setting treatment protocols, or dictating patient fees for medical services. * "Sham" MSO Structures: Where the MSO effectively controls the PC through overly broad management agreements or disproportionate revenue splits that resemble profit sharing for medical services.
2. Moderate Enforcement States (Medium Risk)
These states may have a CPOM doctrine but offer more exceptions or have a less aggressive enforcement history. They might permit corporate employment of physicians under certain conditions or for specific types of entities (e.g., hospitals, PPOs, certain HMOs). However, careful legal analysis is still required to determine the permissible scope of corporate involvement.
Examples: * Florida: While Florida generally has a CPOM doctrine, it allows certain exceptions, such as for health maintenance organizations (HMOs) or for entities providing specific ancillary services. However, the Board of Medicine still monitors arrangements where lay entities exert undue influence over physician practices. *See Florida Statute § 456.053.* * Pennsylvania: Recognizes the CPOM doctrine, but its enforcement can be less explicit than in strict states, often relying on case law and regulatory interpretations. Some corporate structures may be permissible depending on the specific services offered and the level of corporate control. * Massachusetts: Has a CPOM doctrine that generally prohibits the employment of physicians by lay corporations for the practice of medicine, but with specific statutory exceptions for certain types of entities or arrangements. Requires careful review to determine applicability.
3. Permissive/No Explicit CPOM States (Lower Risk, but Not Zero Risk)
Some states do not have an explicit statutory or regulatory CPOM doctrine, or their courts have not upheld such a prohibition. In these states, a corporation may directly employ physicians. However, even in these states, related doctrines like fee-splitting prohibitions, anti-kickback statutes, and prohibitions against unlicensed practice of medicine still apply and can limit corporate structure and operations.
Examples: * Georgia: Does not have a strong statutory or common law CPOM doctrine. Corporations can generally employ physicians, but anti-kickback and fee-splitting laws still apply. * South Carolina: Similar to Georgia, South Carolina generally does not enforce a strong CPOM doctrine, allowing for direct employment of physicians by corporations. * Maryland: The Maryland courts have generally not recognized a common law CPOM doctrine, and there is no explicit statutory prohibition on corporations employing physicians. However, other regulatory concerns like fee-splitting remain relevant.
Important Caveat: Even in
Further Reading
- [The GLP-1 Compounding Quake: FDA's Proposed Ban on 503B Bulks Reshapes Healthcare Business Models](/blog/glp1-compounding-quake-fda-503b-bulks-ban)
- [The Unseen Hand: Navigating Corporate Practice of Medicine (CPOM) Across State Lines in 2025-2026](/blog/cpom-compliance-multi-state-telehealth-2025)
- [Unpacking the Corporate Practice of Medicine: A State-by-State Guide for Telehealth and Multi-State Practices in 2025-2026](/blog/cpom-state-by-state-telehealth-2025-2026)
- [Enforcement Crossroads: Navigating Telehealth Fraud Crackdowns and Evolving Compliance Mandates](/blog/telehealth-fraud-crackdowns-compliance-mandates)